跳至主要内容
临床试验/CTRI/2018/03/012845
CTRI/2018/03/012845招募中未知

Safety and efficacy of oral iron syrup in adolescents, pregnancy and postpartum.

Cadila Pharmaceuticals Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Female subjects
  • 2. Age between 12-40 years
  • 3. Willingness and ability to participate in study procedures
  • 4. Hb of 11 g/dL or less
  • 5. For postpartum women, 10 days or less postpartum
  • 6.For pregnant women, Gestational age beyond 12 weeks
  • 7. Willingness to provide the writeen informed consent

排除标准

  • 1. History of anemia other than iron deficiency anemia
  • 2. Recent blood transfusion
  • 3. Current treatment with myelo suppressive therapy or asthma therapy
  • 4. Intolerance to iron derivatives
  • 5. For postpartum women, the following exclusion criteria will also apply:
  • 1.Significant vaginal bleeding
  • 2. History of blood loss due to delivery being considered for blood transfusion

研究者

相似试验